GlassScriptPhysician profile
William A Rollefson
NPI 1366436750
$73,613.83
in general payments reported to CMS, 2019-2025
21 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $9,774 · 2021: $13K · 2022: $8,664 · 2023: $7,047 · 2024: $5,274 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,700 · Food and Beverage: $3,889 · Travel and Lodging: $1,123 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,700.00 |
| Food and Beverage | $3,888.92 |
| Travel and Lodging | $1,122.52 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $42,233.46 | 2019-2025 | Afx2 Bifurcated Endograft System |
| Terumo Medical Corporation | $20,213.04 | 2019-2020 | |
| Abbott Laboratories | $5,134.72 | 2019-2025 | Navitor, Amplatzer Amulet, Mitraclip |
| Edwards Lifesciences Corporation | $1,526.18 | 2019-2025 | |
| Cardiovascular Systems INC. | $1,458.18 | 2019 | |
| Shockwave Medical, INC | $835.70 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $505.19 | 2019-2025 | Watchman, General - Structural Heart |
| Abiomed | $379.03 | 2019-2023 | Impella |
| Medtronic, INC. | $338.78 | 2021-2023 | Endurant Iis |
| Medtronic Vascular, INC. | $295.59 | 2019 | |
| Livanova USA, INC. | $164.55 | 2021 | |
| Bolton Medical INC | $146.82 | 2022 | |
| Pfizer INC. | $146.53 | 2022-2025 | |
| Cardiva Medical, INC. | $50.88 | 2023 | Cardiva Vascade 6/7f Vcs |
| Novartis Pharmaceuticals Corporation | $41.62 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $41.22 | 2022 | |
| Inari Medical, INC. | $28.19 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $20.08 | 2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $20.00 | 2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $17.18 | 2024 | |
| Novo Nordisk INC | $16.89 | 2024 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rollefson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.